(Q40003162)

16 September 2017

title

Gene expression of survivin and its spliced isoforms associated with proliferation and aggressive phenotypes of prostate cancer (English)

1 reference

16 September 2017

1 reference

Hidekazu Koike

1

1 reference

16 September 2017

Yoshitaka Sekine

2

1 reference

16 September 2017

Makoto Kamiya

3

1 reference

16 September 2017

Haruki Nakazato

4

1 reference

16 September 2017

Kazuhiro Suzuki

5

1 reference

16 September 2017

language of work or name

English

0 references

publication date

12 March 2008

1 reference

16 September 2017

1 reference

16 September 2017

volume

72

1 reference

16 September 2017

issue

6

1 reference

16 September 2017

page(s)

1229-1233

1 reference

Survivin as a target for new anticancer interventions

16 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.12.064

Survivin expression correlates with clinical stage, histological grade, invasive behavior and survival rate in endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.12.064

High expression of Survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.12.064

Expression of survivin in esophageal cancer: correlation with the prognosis and response to chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.12.064

Survivin splice variants regulate the balance between proliferation and cell death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.12.064

Survivin 2alpha: a novel Survivin splice variant expressed in human malignancies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.12.064

Distinct in vivo expression patterns of survivin splice variants in renal cell carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.12.064

Ribozyme-mediated inhibition of survivin expression increases spontaneous and drug-induced apoptosis and decreases the tumorigenic potential of human prostate cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.12.064

Adenoviral infection of survivin antisense sensitizes prostate cancer cells to etoposide in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.12.064

Adenovirus-mediated inhibition of survivin expression sensitizes human prostate cancer cells to paclitaxel in vitro and in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.12.064

Radiosensitization of human melanoma cells by ribozyme-mediated inhibition of survivin expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.12.064

Genistein, a soy isoflavone, induces glutathione peroxidase in the human prostate cancer cell lines LNCaP and PC-3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.12.064

Expression of the survivin gene in prostate cancer: correlation with clinicopathological characteristics, proliferative activity and apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.12.064

Molecular analysis of survivin isoforms: evidence that alternatively spliced variants do not play a role in mitosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.12.064

Do the survivin (BIRC5) splice variants modulate or add to the prognostic value of total survivin in breast cancer?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.12.064

Transcriptional expression of survivin and its splice variants in cervical carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.12.064

Elevated expression of survivin-splice variants predicts a poor outcome for soft-tissue sarcomas patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.12.064

Down-regulation of survivin by antisense oligonucleotides increases apoptosis, inhibits cytokinesis and anchorage-independent growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.12.064

Downregulation of survivin expression by induction of the effector cell protease receptor-1 reduces tumor growth potential and results in an increased sensitivity to anticancer agents in human colon cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.12.064

Ribozyme-mediated cleavage of the human survivin mRNA and inhibition of antiapoptotic function of survivin in MCF-7 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.12.064

Cancer gene therapy using a survivin mutant adenovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.12.064

RNA interference is mediated by 21- and 22-nucleotide RNAs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.12.064

Short interfering RNAs as a tool for cancer gene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.12.064

Expression of survivin and apoptotic biomarkers in benign prostatic hyperplasia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.12.064

10.1016/J.UROLOGY.2007.12.064

7 January 2021

Identifiers

DOI

1 reference

16 September 2017

1 reference